Rexgen Ltd
12606494
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/05/2025
micro entity
Next accounts due
28/02/2027
Confirmation statement
Last: 20/07/2025
Due 03/08/2026
Industry
Officers
director · Since 18/05/2020
BIOTECH
BRITISH · ENGLAND · Age 72
Also on 2 other boards
Persons with Significant Control
Mr Marco Joseph Calzavara
British · England · Age 72
25, Bridge Lane, London, NW11 0ED
Notified 18/05/2020
Change History
Active
Private Limited Company
25 BRIDGE LANE
LONDON
CompanyRankvs 445+ SIC 46750 peers69
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2026
Net Worth
£75k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£75k
Working capital
Current Assets
£97k
Current Liabilities
£22k
Fixed Assets
£1
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 4.49 | -£23k |
| 2025 | 5.21 | -£102 |
| 2024 | 4.98 | +£5k |
| 2023 | 3.74 | — |
Derived from filed accounts. Not audited figures.